Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, G
Right arrow Articles by Habel, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, G
Right arrow Articles by Habel, A
Topic Collections
Right arrowRelevant Article
Thorax 2003;58:306-310
© 2003 BMJ Publishing Group & British Thoracic Society


ASTHMA

Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial

G Roberts1,2, D Newsom3, K Gomez2, A Raffles4, S Saglani4, J Begent4, P Lachman3, K Sloper5, R Buchdahl6, A Habel2 On Behalf Of The North West Thames Asthma Study Group

1 Imperial College School of Medicine at St Mary's Hospital, London, UK
2 West Middlesex Hospital
3 Northwick Park Hospital
4 Queen Elizabeth II Hospital
5 Ealing Hospital
6 Hillingdon Hospital

Correspondence to:
Correspondence to:
Dr G Roberts, Paediatric Respiratory Medicine, Royal London Hospital, London E1 1BB;
g.c.roberts{at}ic.ac.uk

Background: The relative efficacies of aminophylline and salbutamol in severe acute childhood asthma are currently unclear. A single bolus of salbutamol was compared with a continuous aminophylline infusion in children with severe asthma in a randomised double blind study.

Methods: Children aged 1–16 years with acute severe asthma were enrolled if they showed little improvement with three nebulisers (combined salbutamol and ipratropium) administered over an hour and systemic steroids. Subjects were randomised to receive either a short intravenous bolus of salbutamol (15 µg/kg over 20 minutes) followed by a saline infusion or an aminophylline infusion (5 mg/kg over 20 minutes) followed by 0.9 mg/kg/h.

Results: Forty four subjects were enrolled, with 18 randomly allocated to receive salbutamol and 26 to receive aminophylline. The groups were well matched at baseline. An intention to treat analysis showed that there was no statistically significant difference in the asthma severity score (ASS) at 2 hours between the two groups (median (IQR) 6 (6, 8) and 6.5 (5, 8) for salbutamol and aminophylline respectively, p=0.93). A similar improvement in ASS to 2 hours was seen in the two groups (mean difference –0.08, 95% CI –0.97 to 0.80), there was a trend (p=0.07) towards a longer duration of oxygen therapy in the salbutamol group (17.8 hours (95% CI 8.5 to 37.5) v 7.0 hours (95% CI 3.4 to 14.2)), and a significantly (p=0.02) longer length of hospital stay in the salbutamol group (85.4 (95% CI 66.1 to 110.2) hours v 57.3 hours (95% CI 45.6 to 72.0)). There was no significant difference in adverse events between the two groups.

Conclusions: This study suggests that, in severe childhood asthma, there is no significant difference in the effectiveness of a bolus of salbutamol and an aminophylline infusion in the first 2 hours of treatment. Overall, the aminophylline infusion was superior as it significantly reduced the length of stay in hospital.


Keywords: asthma; children; salbutamol; aminophylline


Relevant Article

Airwaves
Wisia Wedzicha
Thorax 2003 58: 283. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
F E Babl, N Sheriff, M Borland, J Acworth, J Neutze, D Krieser, P Ngo, J Schutz, F Thomson, E Cotterell, et al.
Paediatric acute asthma management in Australia and New Zealand: practice patterns in the context of clinical practice guidelines
Arch. Dis. Child., April 1, 2008; 93(4): 307 - 312.
[Abstract] [Full Text] [PDF]


Home page
EDUCATION AND PRACTICEHome page
W. Carroll and W. Lenney
Drug therapy in the management of acute asthma
Arch. Dis. Child. Ed. Pract., June 1, 2007; 92(3): ep82 - ep86.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J Grigg
Management of paediatric asthma
Postgrad. Med. J., September 1, 2004; 80(947): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. F. Donohue
Therapeutic Responses in Asthma and COPD: Bronchodilators
Chest, August 1, 2004; 126(2_suppl_1): 125S - 137S.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
Lucina
Arch. Dis. Child., September 1, 2003; 88(9): 838 - 838.
[Full Text] [PDF]


Home page
ThoraxHome page
M South
Second line treatment for severe acute childhood asthma
Thorax, April 1, 2003; 58(4): 284 - 285.
[Full Text] [PDF]

eLetters:

Read all eLetters

Salbutamol vs aminophylline in severe asthma in children
Florens GA Versteegh
Thorax Online, 23 May 2003 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & British Thoracic Society